Although breast cancer is uncommon in men, it can cause significant morbidity and mortality.
The current review was undertaken to determine whether strategies applied for the …

Introduction Despite its rarity, male breast cancer shows a steadily rising incidence. Given
the absence of ad hoc prospective randomized clinical trials, treatment strategies are based …

Breast cancer is the most common cancer form in women and it has been extensively
studied on the molecular level. Male breast cancer (MBC), on the other hand, is rare and has …

Male breast cancer (BC) is relatively rare, making up less than 1% of all breast cancer cases
in the United States. Treatment guidelines for male BC are derived from studies on the …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Male breast carcinoma is a rare condition. Few male breast cancer-specific epidemiological
or clinical trial data are available-our understanding of male breast cancer thus comes from …

Background Male breast cancer (MBC) is rare. Molecular subtype has been utilized widely
in female breast cancer. But the relationship between subtype and prognosis in MBC …

Background Male breast cancer (MBC) is a rare malignancy. We aimed to analyze the
incidence trends, clinicopathological characteristics, and survival outcomes in early MBC …

Background Male breast cancer is rare and understudied compared with female breast
cancer. A current comparison with female breast cancer could assist in bridging this gap …

Simple Summary In the evolving landscape of breast cancer care, recognizing HER2-low
expression as a target for anti-HER2 therapies has revolutionized treatment approaches …